Valacyclovir exhibits better oral absorption and higher, more prolonged serum concentrations than oral acyclovir. The efficacy of valacyclovir and acyclovir on genital herpes simplex virus (HSV) shedding was assessed in a double-blind, 3-period crossover trial. Sixty-nine immunocompetent participants with genital HSV-2 received oral valacyclovir, acyclovir, and matching placebo in random order for 7-week periods. Participants provided daily genital mucosal swabs for HSV detection by viral culture and polymerase chain reaction (PCR). HSV was detected at least once in 62 (90%) participants by culture and in 68 (98%) by PCR. During placebo, the total HSV shedding rate was 15.4% of days by culture (PCR, 40.2%); the subclinical shedding rate was 6.6% by culture (PCR, 27.1%). Both antivirals were associated with lower HSV shedding by culture (relative risk [RR], 0.03 [95% confidence interval , 0.01–0.07] for valacyclovir and RR, 0.05 [95% CI, 0.03–0.10] for acyclovir) and PCR (RR, 0.18 [95% CI, 0.12–0.26] for valacyclovir and RR, 0.20 [95% CI, 0.15–0.28] for acyclovir), compared with placebo. Genital herpes is a chronic, life-long viral infection. Two types of HSV can cause genital herpes: HSV-1 and HSV-2. Most cases of recurrent genital herpes are caused by HSV-2, and approximately 50 million persons in the United States are infected with this type of genital herpes . Most persons infected with HSV-2 have not had the condition diagnosed. Many such persons have mild or unrecognized infections but shed virus intermittently in the anogenital area. As a result, most genital herpes infections are transmitted by persons unaware that they have the infection or who are asymptomatic when transmission occurs. Management of genital HSV should address the chronic nature of the disease rather than focusing solely on treatment of acute episodes of genital lesions. Metoprolol drug card Tadalafil tablet Prednisone recall For the Valacyclovir HSV Transmission Study Group. Members. The mean rates of recurrence were 0.11 per month and 0.40 per month, respectively P0.001. The benefits and costs of using valacyclovir to reduce transmission in couples. In fact, transmission rates may decrease after source partners disclose 49. Sep 26, 2002. Sept. 27, 2002 -- The drug Valtrex -- prescribed to prevent recurrences of genital herpes -- may actually help prevent the spread of the virus. Sexual transmission of herpes simplex virus type 2 (HSV-2) has been demonstrated from both symptomatic and asymptomatic reactivations in the infected partner. Daily antiviral therapy has been shown to decrease the frequency and amount of genital HSV shedding. Corey and colleagues tested daily valacyclovir for efficacy in preventing sexual transmission of HSV-2 from infected persons to their uninfected partners. The study enrolled monogamous, immunocompetent, heterosexual couples in which only one partner was infected with HSV-2, as demonstrated by Western blot analysis of anti–HSV-2 serum antibodies. Of the initial 4,034 couples screened, 1,385 asymptomatic partners already had serologic evidence of HSV-2 infection and were ineligible, and 799 of the source partners were symptomatic but had negative HSV-2 serology. After informed consent, 352 couples declined to participate, and 14 persons declined to take the study medicines, leaving 1,484 couples (37 percent) available for randomization. The infected source partner of each enrolled couple was randomized to receive valacyclovir in a dosage of 500 mg or placebo taken once daily for eight months. Has your partner, or potential partner, recently informed you that he or she has been diagnosed with genital herpes? After thinking about it, did you decide to continue with the relationship, despite not being infected with the virus that causes genital herpes yourself? Congratulations — the two of you are now a “discordant couple,” which means that one of you has genital herpes and the other doesn’t. While you might have come to the conclusion that acquiring a herpes simplex virus (HSV) infection below the belt won’t be the end of the world, you still might want to You can read all about herpes elsewhere on this blog, but here’s a quick rundown: Genital herpes can be caused by one of two strains of the herpes simplex virus: HSV-1 or HSV-2. While HSV-1 is more commonly associated with cold sores and HSV-2 is more commonly associated with genital herpes, either virus can infect the genital area. One estimate states that 1 out of 6 Americans between 14 to 49 years of age has a genital HSV-2 infection. Since genital herpes infections can also be caused by HSV-1, the number of people with genital herpes is actually higher. Valtrex transmission rates Valtrex effectiveness transmission - MedHelp, Suppressive valacyclovir therapy to reduce genital herpes transmission Valacyclovir dosage for herpesErythromycin ophthalmic ointment purchase Reduction of Transmission The recommended dosage of VALTREX for reduction of transmission of genital herpes in patients with a history of 9 or fewer recurrences per year is 500 mg once daily for the source partner. Valtrex Dosage Guide -. Valtrex Lowers Herpes Transmission - WebMD. Transmission of HSV-2 on Valtrex but Unprotected - Westover Heights Clinic. Jan 10, 2018. Despite a daily regimen of Valacyclovir, commonly known as Valtrex, the HSV-2 transmission rate is only lowered by 50%. Herpes can be. Sep 30, 2013. Other herpes medications include valacyclovir, whose efficacy was. Presumably, HSV transmission rates are higher in the absence of this. Reducing herpes transmission risk with Valtrex. Dear Alice, I am a gay man, and my on-again, off-again boyfriend has genital herpes on his anus. He currently takes.